- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05735002
Promoting Early Diagnosis of Chronic Mesenteric Ischemia (PROMISE)
PRomoting Early Diagnosis Of Chronic Mesenteric ISchEmia by a Mesenteric Artery Calcium Score Based Risk Stratification and Detection of Postprandial Mucosal Ischemia by Butyrate Breath Testing
CMI is an incapacitating disease and timely diagnosis remains problematic. Despite the substantial compensatory capacity of the mesenteric circulation CMI is relatively common, its incidence being comparable to other well-known diseases like Crohn's disease.
Diagnostic tools are needed for two purposes since the exclusion of CMI currently requires a cumbersome complication-prone diagnostic workup and since a definitive diagnosis is mainly established per exclusionem. First, a sensitive test is desirable to rule out CMI and avoid excessive diagnostic investigations. Quantification of mesenteric arterial calcification on computed tomography (CT) seems suitable for this purpose, synonymous with the coronary artery calcium score. Second, a specific test is required confirming CMI by detection of mucosal ischemia during a meal, when oxygen demand peaks. A breath test, based on the requirement of oxygen to absorb and metabolize 13C-butyrate in the enterocyte, could detect mucosal ischemia
Objective: Facilitating diagnosis of chronic mesenteric ischemia (CMI) using 1) the mesenteric artery calcium score (MACS) and 2) mucosal ischemia detection by butyrate breath testing
Study design: Multicentre prospective cohort studies.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with a clinical suspicion of CMI referred to to Maagdarm Ischemie Centrum Rotterdam (MICR).
- Patients ≥ 18 years
Exclusion Criteria:
- Patients who are unable to give informed consent
- Patients with previous mesenteric artery revascularization
- No available CT imaging and contraindications for CT imaging (e.g. pregnancy)
- Common origin of the celiac artery and superior mesenteric artery
- Known delayed gastric emptying
- Known and untreated small intestinal bacterial overgrowth
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Breath test
Time Frame: 2023-2025
|
- To validate the butyrate breath test as a specific functional test with a high positive predictive value to rightfully diagnose and select patients who will benefit from invasive treatment.
|
2023-2025
|
calcium scores
Time Frame: 2023-2035
|
To validate the mesenteric artery calcium score as a readily available, easy, and sensitive test with a high negative predictive value to either rule out CMI or select patients for further investigations.
|
2023-2035
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9933 (Other Identifier: CTRP (Clinical Trial Reporting Program))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Mesenteric Ischemia
-
Erasmus Medical CenterCompleted
-
Oslo University HospitalActive, not recruiting
-
Hospices Civils de LyonRecruitingChronic Mesenteric Ischemia | Stent StenosisFrance
-
University of TartuNot yet recruitingAcute Mesenteric Ischemia
-
University of TartuCompletedAcute Mesenteric IschemiaSwitzerland, Estonia
-
Hospital del MarNot yet recruitingAcute Mesenteric Ischemia
-
Assistance Publique - Hôpitaux de ParisRecruitingAcute Mesenteric IschemiaFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Aalborg University HospitalCompletedAcute Mesenteric Ischemia
-
Tartu University HospitalCompleted
Clinical Trials on 13C-butyrate breath test
-
University Hospital Birmingham NHS Foundation TrustPancreatic Cancer UKRecruitingPancreatic Exocrine InsufficiencyUnited Kingdom
-
Erasmus Medical CenterCompleted
-
Universitaire Ziekenhuizen KU LeuvenCompletedHealthy | Gastric EmptyingBelgium
-
QOL Medical, LLCCompletedCongenital Sucrase-Isomaltase DeficiencyUnited States
-
Cairn DiagnosticsBaylor College of Medicine; Medical College of WisconsinRecruitingGastroparesisUnited States
-
Meridian Bioscience, Inc.CompletedNon-Alcoholic SteatohepatitisUnited States, France, Belgium, United Kingdom
-
University Hospital, AntwerpRecruitingInsulin Resistance | Type 1 DiabetesBelgium
-
Hadassah Medical OrganizationMeridian Bioscience, Inc.Unknown
-
Hadassah Medical OrganizationWithdrawnChronic Hepatitis BIsrael
-
University of New MexicoCompletedCystic FibrosisUnited States